drugset / Trial / NCT05597098

Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women

NCT05597098

Phase 0 Active not recruiting 34 enrolled Queen Mary University of London
Non-randomizedParallel-groupOpen-labelBasic science

Summary

Important differences exist between sexes in incidence, disease patterns and outcomes in coronary artery disease that is not well understood. It is likely that key differences in the underlying biological mechanism, in particular in inflammatory responses, play a part in underpinning these differences. Previous evidence demonstrates that healthy females appear to be more adept at resolving inflammation compared to healthy males. Since inflammation is thought to be a key initiating phenomenon in coronary artery disease the investigators will examine the differences in inflammatory resolution between the sexes in healthy volunteers.

Timeline

Start
2022-12-12
Primary completion
2027-12-12
Completion
2027-12-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cantharidin Small molecule 0.01 ml Topical
Subject Cantharidin Small molecule 0.1 % Topical

Indications

No indication recorded.